KATRINA STACHOWIAK: Open Payments
NPI 1801862842 · BROCKWAY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 17 payments from 8 companies in 2025. Trend: 2023 $203 · 2024 $487 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $147 |
| ABBVIE INC. | 1 | $125 |
| Exact Sciences Corporation | 4 | $68 |
| Lilly USA, LLC | 2 | $40 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Novo Nordisk Inc | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
Products named: QULIPTA, AIRSUPRA, BREZTRI, The Cologuard Plus Collection Kit, MOUNJARO, TRELEGY ELLIPTA, Wegovy, GVOKE HYPOPEN.
Industry payments across MI — which companies pay providers there.
